Patents by Inventor Stephen Gordon Will

Stephen Gordon Will has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11078534
    Abstract: The present invention provides for stable nucleotide reagents used for nucleic acid amplification by PCR and RT-PCR (Reverse Transcriptase-PCR) that comprises modified nucleoside triphosphates. The present invention also provides for methods for using the modified nucleoside triphosphates for detecting the presence or absence of a target nucleic acid sequence in a sample in an amplification reaction.
    Type: Grant
    Filed: November 26, 2018
    Date of Patent: August 3, 2021
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Alexander Nierth, Hannes Kuchelmeister, Concordio Anacleto, Amar Gupta, Dieter Heindl, Igor Kozlov, Christian Wellner, Stephen Gordon Will
  • Publication number: 20190161797
    Abstract: The present invention provides for stable nucleotide reagents used for nucleic acid amplification by PCR and RT-PCR (Reverse Transcriptase-PCR) that comprises modified nucleoside triphosphates. The present invention also provides for methods for using the modified nucleoside triphosphates for detecting the presence or absence of a target nucleic acid sequence in a sample in an amplification reaction.
    Type: Application
    Filed: November 26, 2018
    Publication date: May 30, 2019
    Inventors: Alexander Nierth, Hannes Kuchelmeister, Concordio Anacleto, Amar Gupta, Dieter Heindl, Igor Kozlov, Christian Wellner, Stephen Gordon Will
  • Publication number: 20190093155
    Abstract: The disclosure is a single-tube multiplex assay, capable of simultaneously detecting multiple nucleic acid targets, using multiple hybridization primers and probes, labeled with the same fluorescent reporter label, but each having a distinct annealing temperature. The assay can be further multiplexed with the use of multiple sets of hybridization primers and probes, each set labeled with a separate fluorescent reporter label.
    Type: Application
    Filed: May 23, 2018
    Publication date: March 28, 2019
    Applicant: Roche Molecular Systems, Inc.
    Inventor: Stephen Gordon Will
  • Publication number: 20160348158
    Abstract: The invention provides, inter alia, novel probes, methods, reaction mixtures, and kits for detecting the presence or absence of a target nucleic acid sequence.
    Type: Application
    Filed: May 28, 2015
    Publication date: December 1, 2016
    Inventor: Stephen Gordon Will
  • Patent number: 9371524
    Abstract: A method for isolating a biological target material from a biological sample is provided, the method including binding the target material to a solid support, wherein impurities are selectively removed from the solid support by washing the latter with a wash buffer containing a cationic amine. A kit for isolating a biological target material from a biological sample is also provided, the kit including a wash buffer containing a cationic amine, and the use of a respective wash buffer.
    Type: Grant
    Filed: April 4, 2013
    Date of Patent: June 21, 2016
    Assignee: ROCHE MOLECULAR SYSTEMS, INC.
    Inventor: Stephen Gordon Will
  • Patent number: 8669061
    Abstract: An improved method of preventing carryover contamination of an amplification reaction involves treating uracil-containing DNA with uracil-N-DNA glycosylase and heating the DNA in the presence of polyamines, such as spermidine, spermine and the like. Alternatively, after treatment with uracil-N-DNA glycosylase, the reaction is further incubated with an enzyme having AP lyase activity.
    Type: Grant
    Filed: June 16, 2009
    Date of Patent: March 11, 2014
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Amar Gupta, Stephen Gordon Will, Roy Bohenzky, Janine Montiel
  • Patent number: 8658366
    Abstract: Methods, reaction mixtures and systems for detecting the presence or absence of a target nucleic acid variant from a selection of possible variants is described.
    Type: Grant
    Filed: September 14, 2009
    Date of Patent: February 25, 2014
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Stephen Gordon Will, Amar P. Gupta, Laura Geyer
  • Publication number: 20130266951
    Abstract: A method for isolating a biological target material from a biological sample is provided, the method including binding the target material to a solid support, wherein impurities are selectively removed from the solid support by washing the latter with a wash buffer containing a cationic amine. A kit for isolating a biological target material from a biological sample is also provided, the kit including a wash buffer containing a cationic amine, and the use of a respective wash buffer.
    Type: Application
    Filed: April 4, 2013
    Publication date: October 10, 2013
    Applicant: Roche Molecular Systems, Inc.
    Inventor: Stephen Gordon Will
  • Patent number: 8222003
    Abstract: This invention provides compositions and methods for HCV typing, e.g., genotyping and/or subtyping. The compositions and methods of the invention can be used to assign an HCV isolate to one of at least five HCV genotypes (for example, selected from genotypes 1, 2, 3, 4, 5 or 6), or assign an HCV isolate to one of at least six subtypes (for example, selected from subtypes 1a/b/c, 2a/c, 2b, 3a, 4a, 5a or 6a), where the methods of the invention use only a single typing probe to make the HCV type assignment.
    Type: Grant
    Filed: November 11, 2008
    Date of Patent: July 17, 2012
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Amar P Gupta, Stephen Gordon Will
  • Publication number: 20120070820
    Abstract: This invention provides compositions and methods for HCV typing, e.g., genotyping and/or subtyping. The compositions and methods of the invention can be used to assign an HCV isolate to one of at least five HCV types (for example, selected from types 1, 2, 3, 4, 5 or 6), or to one of at least five subtypes (for example, subtypes 1a/b/c, 2a/c, 2b, 3a, 4a, 5a or 6a). These methods integrate the hybridization data from a plurality of HCV typing probes in a multidimensional analysis to make an HCV type assignment for an HCV in an experimental sample. The invention also provides related compositions, including, for example, the HCV typing probes and HCV typing diagnostic kits.
    Type: Application
    Filed: October 7, 2011
    Publication date: March 22, 2012
    Applicant: ROCHE MOLECULAR SYSTEMS, INC.
    Inventors: Amar P. Gupta, Stephen Gordon Will
  • Patent number: 8114595
    Abstract: The present invention relates to methods and reagents for modifying the emission of light from labeled nucleic acids for the purpose of real time detection, analysis, and quantitation of nucleic acid sequences, e.g., using singly labeled probes. These methods and reagents exploit advantageous properties of thiazine dyes and diazine dyes. Furthermore, the use of these light emission modifiers in background reduction, nucleic acid duplex stabilization and other uses is also described. Related kits, reaction mixtures and integrated systems are described.
    Type: Grant
    Filed: September 1, 2009
    Date of Patent: February 14, 2012
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Amar P. Gupta, Stephen Gordon Will
  • Patent number: 8067208
    Abstract: This invention provides compositions and methods for HCV typing, e.g., genotyping and/or subtyping. The compositions and methods of the invention can be used to assign an HCV isolate to one of at least five HCV types (for example, selected from types 1, 2, 3, 4, 5 or 6), or to one of at least five subtypes (for example, subtypes 1a/b/c, 2a/c, 2b, 3a, 4a, 5a or 6a). These methods integrate the hybridization data from a plurality of HCV typing probes in a multidimensional analysis to make an HCV type assignment for an HCV in an experimental sample. The invention also provides related compositions, including, for example, the HCV typing probes and HCV typing diagnostic kits.
    Type: Grant
    Filed: June 23, 2006
    Date of Patent: November 29, 2011
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Amar P. Gupta, Stephen Gordon Will
  • Patent number: 8058423
    Abstract: This invention provides compositions and methods for detecting HPV in a sample. This invention also provides related kits, systems, and computers.
    Type: Grant
    Filed: December 10, 2008
    Date of Patent: November 15, 2011
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Janet Kornegay, Carrie L. Aldrich, Stephen Gordon Will
  • Patent number: 7977108
    Abstract: The present invention provides methods and probe nucleic acids for detecting mutant forms of target nucleic acids that comprise repetitive nucleotide sequences. In certain embodiments, for example, these approaches and reagents can be used to detect instability in regions of genomic DNA that include microsatellite markers. The invention also provides related reaction mixtures, systems, and kits.
    Type: Grant
    Filed: July 13, 2006
    Date of Patent: July 12, 2011
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Christopher D. Newhouse, Stephen Gordon Will, Amar P. Gupta
  • Patent number: 7947817
    Abstract: The invention provides compositions that comprise nucleotides and/or nucleosides having blocking groups at 2?-positions of sugar moieties. Methods of synthesizing these nucleic acids are also provided.
    Type: Grant
    Filed: June 28, 2004
    Date of Patent: May 24, 2011
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Veeraiah Bodepudi, Stephen Gordon Will, David Harrow Gelfand
  • Patent number: 7919242
    Abstract: The present invention relates to methods and reagents for modifying the emission of light from labeled nucleic acids for the purpose of real time detection, analysis, and quantitation of nucleic acid sequences, e.g., using singly labeled probes. These methods and reagents exploit advantageous properties of thiazine dyes and diazine dyes. Furthermore, the use of these light emission modifiers in background reduction, nucleic acid duplex stabilization and other uses is also described. Related kits, reaction mixtures and integrated systems are described.
    Type: Grant
    Filed: June 23, 2006
    Date of Patent: April 5, 2011
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Amar P. Gupta, Stephen Gordon Will
  • Publication number: 20100124744
    Abstract: Methods, reaction mixtures and systems for detecting the presence or absence of a target nucleic acid variant from a selection of possible variants is described.
    Type: Application
    Filed: September 14, 2009
    Publication date: May 20, 2010
    Applicant: Roche Molecular Systems, Inc.
    Inventors: Stephen Gordon Will, Amar P. Gupta, Laura Geyer
  • Publication number: 20100093041
    Abstract: An improved method of preventing carryover contamination of an amplification reaction involves treating uracil-containing DNA with uracil-N-DNA glycosylase and heating the DNA in the presence of polyamines, such as spermidine, spermine and the like. Alternatively, after treatment with uracil-N-DNA glycosylase, the reaction is further incubated with an enzyme having AP lyase activity.
    Type: Application
    Filed: June 16, 2009
    Publication date: April 15, 2010
    Applicant: ROCHE MOLECULAR SYSTEMS, INC.
    Inventors: Amar Gupta, Stephen Gordon Will, Roy Bohenzky, Janine Montiel
  • Publication number: 20100015598
    Abstract: The present invention relates to methods and reagents for modifying the emission of light from labeled nucleic acids for the purpose of real time detection, analysis, and quantitation of nucleic acid sequences, e.g., using singly labeled probes. These methods and reagents exploit advantageous properties of thiazine dyes and diazine dyes. Furthermore, the use of these light emission modifiers in background reduction, nucleic acid duplex stabilization and other uses is also described. Related kits, reaction mixtures and integrated systems are described.
    Type: Application
    Filed: September 1, 2009
    Publication date: January 21, 2010
    Applicant: ROCHE MOLECULAR SYSTEM, INC.
    Inventors: Amar P. Gupta, Stephen Gordon Will
  • Publication number: 20100015630
    Abstract: The present invention relates to methods and reagents for modifying the emission of light from labeled nucleic acids for the purpose of real time detection, analysis, and quantitation of nucleic acid sequences, e.g., using singly labeled probes. These methods and reagents exploit advantageous properties of thiazine dyes and diazine dyes. Furthermore, the use of these light emission modifiers in background reduction, nucleic acid duplex stabilization and other uses is also described. Related kits, reaction mixtures and integrated systems are described.
    Type: Application
    Filed: September 1, 2009
    Publication date: January 21, 2010
    Applicant: ROCHE MOLECULAR SYSTEM, INC.
    Inventors: Amar P. Gupta, Stephen Gordon Will